The invention relates to a pharmaceutical composition comprising a variant TNF-.alpha. protein that inhibits the activity of soluble TNF-.alpha. while substantially maintaining the activity of transmembrane TNF-.alpha. a buffer and a tonicity agent wherein said composition has a pH from approximately 5.0 to 8.0.

 
Web www.patentalert.com

< Energy absorbent material

> Compositions and methods for treatment of microbial infections

> Disposable component on a fuel cartridge and for use with a portable fuel cell system
~ 00580